A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.

Pancreatic cancer cells can regulate their tolerance to chemotherapy depending on what they detect in their surroundings, according to NYU Langone researchers. With that, it’s unlikely that a single ...

Scientists at UCLA have developed an “off-the-shelf” cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs. In a mouse study, ...

A new study has revealed a promising new approach to curb the spread of triple-negative breast cancer, one of the most ...

A group of natural compounds attracting attention for their anti-aging potential has a dark side. New research shows how a ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Universal, off‑the‑shelf CAR‑T cell therapies using gene‑edited donor T cells are beginning ...

The University of Iowa Health Care Holden Comprehensive Cancer Center has started treating its second patient — the second in the state — with a cellular therapy to fight synovial sarcoma, a rare and ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

New research suggests childhood cancer survivors may experience accelerated biological aging from treatments, potentially ...

A modified herpes virus boosted immune T cell infiltration in glioblastoma tumors and was associated with improved survival.

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.